FULCRUM THERAPEUTICS INC
FULCNASDAQ๐ #3440 by market capEarnings Oct 29US Equity
$3.70โผ $0.02 (โ0.54%)
๐
Pre-market$3.71โฒ 0.27%Regular close ยท extended-hours price shownTrack FULC
Get earnings, price moves & breaking news on Telegram
24hโผ 0.5%
7dโผ 3.0%
14dโผ 2.1%
30dโผ 4.9%
ytdโผ 67.3%
1yโผ 59.8%
๐ฆMarket Cap
$282M
Small Cap
๐Revenue Growth (YoY)
-100.0%
Declining
๐Gross Margin
0.0%
Thin
๐ตFCF Margin
0.0%
Thin
โ๏ธP/S Ratio
0.0x
Cheap
Otter Score
64
Fair
FULCRUM THERAPEUTICS INC
FULCAnalyst Ratings
Price
$3.70
Total
17
Raised
1
Lowered
7
Avg PT
$3.60
H / L
$4 / $3
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
JP Morgan | Downgraded | Overweight โ Underweight | 2026-06-03 | โ | โ |
Piper Sandler | Downgraded | Overweight โ Underweight | 2026-06-02 | $3.00 | โ18.90% |
Truist Securities | Downgraded | Buy โ Hold | 2026-06-02 | โ | โ |
Leerink Partners | Downgraded | Outperform โ Market Perform | 2026-06-02 | $4.00 | +8.10% |
HC Wainwright & Co. | Downgraded | Buy โ Neutral | 2026-06-02 | โ | โ |
Stifel | Downgraded | Buy โ Hold | 2026-06-02 | โ | โ |
B of A Securities | Reiterated | Underperform | 2025-12-09 | โ | โ |
RBC Capital | Reiterated | Sector Perform | 2025-12-08 | $10.00 | +170.30% |
Cantor Fitzgerald | Reiterated | Overweight | 2025-12-08 | $24.00 | +548.60% |
Oppenheimer | Reiterated | Outperform | 2024-05-14 | โ | โ |
Goldman Sachs | Upgraded | Neutral โ Buy | 2024-05-14 | $15.00 | +305.40% |
Morgan Stanley | Reiterated | Equal Weight | 2023-03-10 | โ | โ |
Credit Suisse | Downgraded | Outperform โ Neutral | 2023-03-10 | โ | โ |
SVB Leerink | Reiterated | Outperform | 2021-08-13 | โ | โ |
BTIG | Reiterated | Buy | 2020-06-17 | โ | โ |
H.C. Wainwright | Reiterated | Buy | 2020-03-06 | $3.00 | โ18.90% |
Bank of America | Reiterated | Buy | 2019-08-12 | โ | โ |
Institution
JP Morgan
Downgraded ยท Overweight โ Underweight ยท 2026-06-03
โ
โ
Piper Sandler
Downgraded ยท Overweight โ Underweight ยท 2026-06-02
$3.00
โ18.90%
Truist Securities
Downgraded ยท Buy โ Hold ยท 2026-06-02
โ
โ
Leerink Partners
Downgraded ยท Outperform โ Market Perform ยท 2026-06-02
$4.00
+8.10%
HC Wainwright & Co.
Downgraded ยท Buy โ Neutral ยท 2026-06-02
โ
โ
Stifel
Downgraded ยท Buy โ Hold ยท 2026-06-02
โ
โ
B of A Securities
Reiterated ยท Underperform ยท 2025-12-09
โ
โ
RBC Capital
Reiterated ยท Sector Perform ยท 2025-12-08
$10.00
+170.30%
Cantor Fitzgerald
Reiterated ยท Overweight ยท 2025-12-08
$24.00
+548.60%
Oppenheimer
Reiterated ยท Outperform ยท 2024-05-14
โ
โ
Goldman Sachs
Upgraded ยท Neutral โ Buy ยท 2024-05-14
$15.00
+305.40%
Morgan Stanley
Reiterated ยท Equal Weight ยท 2023-03-10
โ
โ
Credit Suisse
Downgraded ยท Outperform โ Neutral ยท 2023-03-10
โ
โ
SVB Leerink
Reiterated ยท Outperform ยท 2021-08-13
โ
โ
BTIG
Reiterated ยท Buy ยท 2020-06-17
โ
โ
H.C. Wainwright
Reiterated ยท Buy ยท 2020-03-06
$3.00
โ18.90%
Bank of America
Reiterated ยท Buy ยท 2019-08-12
โ
โ
One row per institution ยท price target from the firm's latest published target